Marie-Anne Petit，克拉马，法国——HBV相关实验室及人物介绍
本帖最后由 bigben446 于 2016-5-10 04:24 编辑Marie-Anne Petit，克拉马，法国——HBV相关实验室及人物介绍系列
Marie-Anne Petit，INSERM，Clamart, France
Favre, D. and M. A. Petit, et al. (2003). "Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro." ALTEX 20(3): 131-42.
Gheit, T. and S. Sekkat, et al. (2002). "Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus." J Gen Virol 83(Pt 7): 1645-9.
Petit, M. A. and G. D. Buffello-Le, et al. (2001). "Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen." J Med Virol 65(3): 493-504.
Le Guillou, D. B. and J. C. Duclos-Vallee, et al. (2000). "Evaluation of an enzyme-linked immunosorbent assay for detection and quantification of hepatitis B virus PreS1 envelope antigen in serum samples: comparison with two commercial assays for monitoring hepatitis B virus DNA." J Viral Hepat 7(5): 387-92.
Pichoud, C. and F. Berby, et al. (2000). "Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B." J Hepatol 32(2): 307-16.
Duclos-Vallee, J. C. and F. Capel, et al. (1998). "Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity." J Gen Virol 79 ( Pt 7): 1665-70.
Leroux-Roels, G. and I. Desombere, et al. (1997). "Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines." Vaccine 15(16): 1732-6.
Leroux-Roels, G. and I. Desombere, et al. (1997). "Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults." Vaccine 15(16): 1724-31.
Pollicino, T. and A. R. Zanetti, et al. (1997). "Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis." Hepatology 26(2): 495-9.
Oquendo, J. and S. Karray, et al. (1997). "Effect of hepatitis B virus on tumour necrosis factor (TNF alpha) gene expression in human THP-1 monocytic and Namalwa B-cell lines." Res Immunol 148(6): 399-409.
Oquendo, J. and S. Dubanchet, et al. (1996). "Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line." Eur Cytokine Netw 7(4): 793-800.
Berthillon, P. and J. M. Crance, et al. (1996). "Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteinsby interferon in a human hepatocarcinoma cell line (PLC/PRF/5)." J Hepatol 25(1): 15-9.
Kremsdorf, D. and F. Garreau, et al. (1996). "In vivo selection of a hepatitis B virus mutant with abnormal viral protein expression." J Gen Virol 77 ( Pt 5): 929-39.
Mabit, H. and C. Vons, et al. (1996). "Primary cultured normal human hepatocytes for hepatitis B virus receptor studies." J Hepatol 24(4): 403-12.
Zoulim, F. and F. Capel, et al. (1995). "." Gastroenterol Clin Biol 19(12): 970-5.
Ganne-Carrie, N. and D. Kremsdorf, et al. (1995). "Effects of ethanol on hepatitis B virus Pre-S/S gene expression in the human hepatocellular carcinoma derived HEP G2 hepatitis B DNA positive cell line." J Hepatol 23(2): 153-9.
Rosmorduc, O. and M. A. Petit, et al. (1995). "In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA." Hepatology 22(1): 10-9.
Mabit, H. and S. Dubanchet, et al. (1994). "In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV):spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences." J Gen Virol 75 ( Pt 10): 2681-9.
Petit, M. A. and F. Zoulim, et al. (1994). "PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B." J Hepatol 20(1): 47-56.
Kremsdorf, D. and F. Garreau, et al. (1993). "Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient." J Hepatol 18(2): 244-50.
Trepo, C. and F. Zoulim, et al. (1993). "Diagnostic markers of viral hepatitis B and C." Gut 34(2 Suppl): S20-5.
Petit, M. A. and F. Capel, et al. (1993). "Significance and relevance of serum preS1 antigen detection in wild-type and variant hepatitis B virus (HBV) infections." Arch Virol Suppl 8: 179-87.
Emilie, D. and E. Navratil, et al. (1992). "In situ activation of B lymphocytes in hepatitis B virus-induced fulminant hepatitis." Eur J Med 1(7): 431-3.
Petit, M. A. and F. Capel, et al. (1992). "PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes." Virology 187(1): 211-22.
Petit, M. A. and F. Capel, et al. (1992). "PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response." Arch Virol Suppl 4: 105-12.
Terre, S. and M. A. Petit, et al. (1991). "Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo." J Virol 65(10): 5539-43.
Gerken, G. and D. Kremsdorf, et al. (1991). "Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection." Virology 183(2): 555-65.
Tran, A. and D. Kremsdorf, et al. (1991). "Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection." J Virol 65(7): 3566-74.
Petit, M. A. and S. Dubanchet, et al. (1991). "HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47)." Virology 180(2): 483-91.
Chemin, I. and I. Baginski, et al. (1991). "Correlation between HBV DNA detection by polymerase chain reaction and Pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections." J Med Virol 33(1): 51-7.
Terre, S. and O. Rosmorduc, et al. (1991). "Reverse transcription and packaging of hepatitis B virus (HBV)-RNA generates in vivo defective serum HBV particles." J Hepatol 13 Suppl 4: S42-8.
Gerken, G. and D. Kremsdorf, et al. (1991). "Hepatitis B defective virus with rearrangements in the preS gene during HBV chronic infection." J Hepatol 13 Suppl 4: S93-6.
Bchini, R. and F. Capel, et al. (1990). "In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus." J Virol 64(6): 3025-32.
Petit, M. A. and F. Zoulim, et al. (1990). "Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication." Hepatology 11(5): 809-14.
Trepo, C. and I. Chemin, et al. (1990). "Possible prevention of chronic hepatitis B by early interferon therapy." J Hepatol 11 Suppl 1: S95-9.
Ferrari, C. and A. Penna, et al. (1990). "Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection." J Immunol 145(10): 3442-9.
Petit, M. A. and S. Dubanchet, et al. (1989). "A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus." Mol Immunol 26(6): 531-7.
Pontisso, P. and M. A. Petit, et al. (1989). "Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region." J Virol 63(5): 1981-8.
Petit, M. A. and F. Capel, et al. (1987). "Antigenic mapping of the surface proteins of infectious hepatitis B virus particles." J Gen Virol 68 ( Pt 11): 2759-67.
Neurath, A. R. and S. B. Kent, et al. (1987). "Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes." Mol Immunol 24(9): 975-80.
Neurath, A. R. and S. B. Kent, et al. (1987). "Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw." Mol Immunol 24(6): 561-8.
Budkowska, A. and M. M. Riottot, et al. (1986). "Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody." J Med Virol 20(2): 111-25.
Neurath, A. R. and P. Adamowicz, et al. (1986). "Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein." Mol Immunol 23(9): 991-7.
Petit, M. A. and P. Maillard, et al. (1986). "Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins." Mol Immunol 23(5): 511-23.
Petit, M. A. and F. Capel, et al. (1985). "Demonstration of a firm association between hepatitis B surface antigen proteinsbearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles." Mol Immunol 22(11): 1279-87.
Petit, M. A. and J. Pillot (1985). "HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells." J Virol 53(2): 543-51.
Budkowska, A. and M. A. Petit, et al. (1984). "Isolation and characterization of liver-derived hepatitis B e antigen." J Med Virol 13(3): 269-79.
Pillot, J. and M. A. Petit (1984). "Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting." Mol Immunol 21(1): 53-60.
页:
[1]